Close
  Indian J Med Microbiol
 

Figure 2: Multivariate Cox proportional regression analysis for efficacy, safety, and other prognostic endpoints. HRs before (a) and after PSM (b). *Adjusted for hospital stay, staged PCI, previous CABG, hypertension, number of TVs, LAD/LCX/RCA involvement, de novo/B2/C type/CTO lesion, stent overlapping, IABP application, average stent length, and use of β-blockers and DAPT for 2 years. CABG: Coronary artery bypass grafting; CI: Confidence interval; CTO: Chronic total occlusion; DAPT: Dual antiplatelet therapy; G1-DES: First-generation drug-eluting stent; G2-DES: Second-generation drug-eluting stent; HRs: Hazard ratios; IABP: Intra-aortic balloon pumping; LAD: Left anterior descending artery; LCX: Left circumflex artery; MACEs: Major adverse cardiac events; MI: Myocardial infarction; PCI: Percutaneous coronary intervention; PSM: Propensity score matching; RCA: Right coronary artery; TLR: Target lesion revascularization; TV: Target vessel; TV-MI: Target vessel-related myocardial infarction; TVR: Target vessel revascularization.

Figure 2: Multivariate Cox proportional regression analysis for efficacy, safety, and other prognostic endpoints. <i>HRs</i> before (a) and after PSM (b). *Adjusted for hospital stay, staged PCI, previous CABG, hypertension, number of TVs, LAD/LCX/RCA involvement, <i>de novo</i>/B<sub>2</sub>/C type/CTO lesion, stent overlapping, IABP application, average stent length, and use of β-blockers and DAPT for 2 years. CABG: Coronary artery bypass grafting; CI: Confidence interval; CTO: Chronic total occlusion; DAPT: Dual antiplatelet therapy; G1-DES: First-generation drug-eluting stent; G2-DES: Second-generation drug-eluting stent; <i>HRs</i>: Hazard ratios; IABP: Intra-aortic balloon pumping; LAD: Left anterior descending artery; LCX: Left circumflex artery; MACEs: Major adverse cardiac events; MI: Myocardial infarction; PCI: Percutaneous coronary intervention; PSM: Propensity score matching; RCA: Right coronary artery; TLR: Target lesion revascularization; TV: Target vessel; TV-MI: Target vessel-related myocardial infarction; TVR: Target vessel revascularization.